Your browser doesn't support javascript.
loading
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
Wang, Feng-Hua; Zhang, Xiao-Tian; Tang, Lei; Wu, Qi; Cai, Mu-Yan; Li, Yuan-Fang; Qu, Xiu-Juan; Qiu, Hong; Zhang, Yu-Jing; Ying, Jie-Er; Zhang, Jun; Sun, Ling-Yu; Lin, Rong-Bo; Wang, Chang; Liu, Hao; Qiu, Miao-Zhen; Guan, Wen-Long; Rao, Sheng-Xiang; Ji, Jia-Fu; Xin, Yan; Sheng, Wei-Qi; Xu, Hui-Mian; Zhou, Zhi-Wei; Zhou, Ai-Ping; Jin, Jing; Yuan, Xiang-Lin; Bi, Feng; Liu, Tian-Shu; Liang, Han; Zhang, Yan-Qiao; Li, Guo-Xin; Liang, Jun; Liu, Bao-Rui; Shen, Lin; Li, Jin; Xu, Rui-Hua.
Affiliation
  • Wang FH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Zhang XT; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, P. R. China.
  • Tang L; Department of Radiology, Peking University Cancer Hospital, Beijing, P. R. China.
  • Wu Q; Department of Endoscopy Center, Peking University Cancer Hospital, Beijing, P. R. China.
  • Cai MY; Department of Pathology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Li YF; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Qu XJ; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, P. R. China.
  • Qiu H; Department of Medical Oncology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
  • Zhang YJ; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Ying JE; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, P. R. China.
  • Zhang J; Department of Medical Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P. R. China.
  • Sun LY; Department of Surgical Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China.
  • Lin RB; Department of Medical Oncology, Fujian Cancer Hospital, Fuzhou, Fujian, P. R. China.
  • Wang C; Tumor Center, The First Hospital of Jilin University, Changchun, Jilin, P. R. China.
  • Liu H; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
  • Qiu MZ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Guan WL; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Rao SX; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
  • Ji JF; Department of Gastrointestinal Surgery, Peking University Cancer Hospital, Beijing, P. R. China.
  • Xin Y; Pathology Laboratory of Gastrointestinal Tumor, The First Hospital of China Medical University, Shenyang, Liaoning, P. R. China.
  • Sheng WQ; Department of Pathology, Zhongshan Hospital Affiliated to Shanghai Fudan University, Shanghai, P. R. China.
  • Xu HM; Department of Gastrointestinal Oncology Surgery. The First Hospital of China Medical University, Shenyang, Liaoning, P. R. China.
  • Zhou ZW; Department of Gastric Surgery, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Zhou AP; Department of Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Jin J; Department of Radiation Oncology, Shenzhen hospital, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing, P. R. China.
  • Yuan XL; Department of Oncology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
  • Bi F; Department of Abdominal Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, P. R. China.
  • Liu TS; Department of Medical Oncology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, P. R. China.
  • Liang H; Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, Tianjin, P. R. China.
  • Zhang YQ; Department of Medical Oncology, Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China.
  • Li GX; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
  • Liang J; Department of Medical Oncology, Peking University International Hospital, Beijing, P. R. China.
  • Liu BR; Department of Medical Oncology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, P. R. China.
  • Shen L; Department of GI Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, P. R. China.
  • Li J; Department of Oncology, Easter Hospital affiliated to Shanghai Tongji University, Shanghai, P. R. China.
  • Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
Cancer Commun (Lond) ; 44(1): 127-172, 2024 01.
Article in En | MEDLINE | ID: mdl-38160327
ABSTRACT
The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence-based medicine, healthcare resource availability, and precision medicine. These updates address the differences in epidemiological characteristics, clinicopathological features, tumor biology, treatment patterns, and drug selections between Eastern and Western gastric cancer patients. Key revisions include a structured template for imaging diagnosis reports, updated standards for molecular marker testing in pathological diagnosis, and an elevated recommendation for neoadjuvant chemotherapy in stage III gastric cancer. For advanced metastatic gastric cancer, the guidelines introduce new recommendations for immunotherapy, anti-angiogenic therapy and targeted drugs, along with updated management strategies for human epidermal growth factor receptor 2 (HER2)-positive and deficient DNA mismatch repair (dMMR)/microsatellite instability-high (MSI-H) patients. Additionally, the guidelines offer detailed screening recommendations for hereditary gastric cancer and an appendix listing drug treatment regimens for various stages of gastric cancer. The 2023 CSCO Clinical Guidelines for Gastric Cancer updates are based on both Chinese and international clinical research and expert consensus to enhance their applicability and relevance in clinical practice, particularly in the heterogeneous healthcare landscape of China, while maintaining a commitment to scientific rigor, impartiality, and timely revisions.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms Limits: Humans Country/Region as subject: Asia Language: En Journal: Cancer Commun (Lond) Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms Limits: Humans Country/Region as subject: Asia Language: En Journal: Cancer Commun (Lond) Year: 2024 Type: Article